Imagine trying to build a delicate house of cards while juggling explosives. That's roughly what pharmaceutical chemists have been doing for decades when making important medicines — working with powerful chemicals that can be dangerous to store and transport.
But now, researchers at the University of Osaka in Japan have found a safer path forward. Led by Professor Shinobu Takizawa at SANKEN, the team developed a method that makes a hazardous oxidant called mCPBA only when it's needed, using nothing more than sunlight or ordinary LED lights and the oxygen already in the air.
The oxidant mCPBA (full name: meta-chloroperbenzoic acid) is traditionally used to create Davis reagents — important building blocks for making pharmaceutical molecules. The problem is that mCPBA can explode. Handling large amounts of it during manufacturing creates serious safety risks.
The new approach sidesteps that danger entirely. Instead of storing the oxidant, the team produces it on the spot from a simple starting material called meta-chlorobenzaldehyde, along with light and oxygen. The key innovation is that the oxidant forms but doesn't build up — kinetic analysis showed it gets consumed almost instantly as it's created, so it never reaches dangerous levels.
"Kinetically guided on-demand mCPBA generation enables safe and sustainable light-driven synthesis of Davis reagents," the team reported in the journal Green Chemistry. The researchers even ran the reaction outdoors using actual sunlight and still achieved a 76% isolated yield at gram scale — a result that shows the method could work in real factories, not just labs.
The process also checks several boxes for green chemistry. It runs at room temperature, avoids harsh halogenated solvents, and needs only low-energy light sources. Professor Takizawa called it a step toward manufacturing that combines safety with environmental responsibility.
"Developing technologies that manufacture essential compounds for fine organic synthesis in safer and more environmentally friendly ways is an important challenge for realizing a sustainable society," Takizawa said.
For patients, this might eventually mean a quieter, cleaner, and safer supply of the medicines they rely on — made possible by the sun.